FDA under fire over Ranbaxy imbroglio
http://www.thehindu.com/business/Industry/fda-under-fire-over-ranbaxy-imbroglio/article4763343.ece
From the article:
Yet, in 2009, a government watchdog, the Government Accountability Office, discovered that only 11 per cent of foreign drug manufacturing plants were inspected by regulators, compared to 40 per cent of domestic plants and the quality of foreign inspections has been described as “questionable.”
Maybe we now know why some generics are available at such a “low price” ?
Filed under: General Problems
Leave a Reply